Article Details

Chinese biotech startup Ionova secures $100m to advance oncology drug pipeline - DealStreetAsia

Retrieved on: 2021-08-23 03:45:00

Tags for this article:

Click the tags to see associated articles and topics

Chinese biotech startup Ionova secures $100m to advance oncology drug pipeline - DealStreetAsia. View article details on hiswai:

Excerpt

Existing shareholders Lilly Asia Ventures (LAV), a biomedical venture capital (VC) firm; and DYEE Capital, which focuses on the healthcare and modern service ...

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up